Triple Antibody Therapy Shows Promise for Long-Lasting HIV Control

In a study of 12 participants, researchers at Beth Israel Deaconess Medical Center (BIDMC) have demonstrated that a cocktail of three broadly neutralizing antibodies (bNAb) successfully suppressed virus in people living with HIV. A subset of participants also demonstrated long-term control of the virus months after antibody levels declined to low or undetectable.

Rutgers Expert Available to Speak About COVID-19 and Heightened Risk for Those Living with HIV

Preliminary data has shown that people living with HIV may be at heightened risk for severe complications from COVID-19 because they are simultaneously experiencing two epidemics that are synergistically interacting to create increased odds of death and disability. However, HIV…